Status:
COMPLETED
Maxillary Sinus Floor Augmentation With Different Grafting Materials
Lead Sponsor:
Aalborg University Hospital
Conditions:
Survival, Prosthesis
Peri-Implantitis
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Implant placement in the posterior maxilla is compromised due to atrophy of the alveolar process and maxillary sinus pneumatisation. Bone augmentation is frequently necessary before or in conjunction ...
Detailed Description
Maxillary sinus floor augmentation (MSFA) is the most frequently used method to enhance the alveolar bone of the posterior maxilla before or in conjunction with implant placement. Autogenous bone is c...
Eligibility Criteria
Inclusion
- \>20 years
- Missing one or more posterior maxillary teeth
- Residual bone height of the maxillary alveolar process between 3 to 7 mm
- Width of the alveolar process ≥6.5 mm.
- Mandibular occluding teeth
Exclusion
- Contraindications to implant therapy
- Full mouth plaque score \>25%
- Progressive marginal periodontitis
- Acute infection in the area intended for implant placement
- Parafunction, bruxism, or clenching
- Psychiatric problems or unrealistic expectations
- Heavy tobacco use, define as \>10 cigarettes per day
- Pregnancy
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04749953
Start Date
January 1 2020
End Date
January 20 2021
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, North Denmark, Denmark, 9000